Viewing StudyNCT06205498



Ignite Creation Date: 2024-05-06 @ 7:59 PM
Last Modification Date: 2024-10-26 @ 3:18 PM
Study NCT ID: NCT06205498
Status: RECRUITING
Last Update Posted: 2024-06-26
First Post: 2023-07-06

Brief Title: Acalabrutinib Real World Italian obSErvational Study -ARISE
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Chronic Lymphocytic Leukemia
Keywords:
Name View
Observational View
Chronic Lymphocytic Leukemia View
acalabrutinib View
CLL View